PharmaCyte Biotech (PMCB) Shares Repurchased (2022 - 2026)
PharmaCyte Biotech (PMCB) has disclosed Shares Repurchased for 5 consecutive years, with $401625.0 as the latest value for Q1 2026.
- Quarterly Shares Repurchased rose 78.48% to $401625.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $573168.0 through Jan 2026, down 83.83% year-over-year, with the annual reading at $2.5 million for FY2025, 90.98% down from the prior year.
- Shares Repurchased for Q1 2026 was $401625.0 at PharmaCyte Biotech, up from $171543.0 in the prior quarter.
- The five-year high for Shares Repurchased was $26.5 million in Q3 2023, with the low at $164953.0 in Q4 2023.
- Average Shares Repurchased over 5 years is $3.4 million, with a median of $1.2 million recorded in 2024.
- The sharpest move saw Shares Repurchased surged 1165.39% in 2023, then crashed 97.19% in 2024.
- Over 5 years, Shares Repurchased stood at $3.4 million in 2022, then plummeted by 95.13% to $164953.0 in 2023, then soared by 750.87% to $1.4 million in 2024, then tumbled by 87.78% to $171543.0 in 2025, then surged by 134.12% to $401625.0 in 2026.
- According to Business Quant data, Shares Repurchased over the past three periods came in at $401625.0, $171543.0, and $225025.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.